skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume

Abstract

Purpose: To investigate the impact of tumor volume on overall survival in patients with Stage III non-small-cell lung cancer (NSCLC) treated with definitive radiation therapy (RT). Methods and Materials: Between May 1997 and February 2003, 71 patients with Stage III NSCLC were treated with radiation therapy of 60 Gy or more. The total target dose was between 60 and 77 Gy (average, 66.3 Gy). Chemotherapy was used in 45 cases. The primary tumor and nodal volume were identified in pretreatment computed tomography scans. Univariate and multivariate analyses were used to evaluate the impact of tumor volume on survival after RT. Results: The overall 2-year survival rate was 23%, with a median survival time of 14 months. The median survival times were 10 months and 19 months with large primary tumor volume more than median volume and smaller primary tumor volume, respectively. At a univariate analysis, the total tumor volume (TTV) (p < 0.0003) and the primary tumor volume (p < 0.00008) were significant and the nodal volume was not. At multivariate analyses, both the TTV and the primary tumor volume were significant prognostic factors. Conclusion: The primary tumor volume as well as TTV is a significant prognostic factor on survivalmore » in patients with Stage III NSCLC treated with RT and should be recorded in clinical results when the survivals are compared among clinical studies.« less

Authors:
 [1];  [2];  [2];  [2];  [2];  [3]
  1. Department of Radiology, Hirosaki University School of Medicine, Aomori (Japan). E-mail: basaki-rad@umin.ac.jp
  2. Department of Radiology, Hirosaki University School of Medicine, Aomori (Japan)
  3. Department of Social Medicine, Hirosaki University School of Medicine, Aomori (Japan)
Publication Date:
OSTI Identifier:
20793303
Resource Type:
Journal Article
Resource Relation:
Journal Name: International Journal of Radiation Oncology, Biology and Physics; Journal Volume: 64; Journal Issue: 2; Other Information: DOI: 10.1016/j.ijrobp.2005.07.967; PII: S0360-3016(05)02216-9; Copyright (c) 2006 Elsevier Science B.V., Amsterdam, Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; CARCINOMAS; CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; LUNGS; MULTIVARIATE ANALYSIS; PATIENTS; RADIOTHERAPY; SURVIVAL TIME

Citation Formats

Basaki, Kiyoshi, Abe, Yoshinao, Aoki, Masahiko, Kondo, Hidehiro, Hatayama, Yoshiomi, and Nakaji, Shigeyuki. Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume. United States: N. p., 2006. Web. doi:10.1016/J.IJROBP.2005.0.
Basaki, Kiyoshi, Abe, Yoshinao, Aoki, Masahiko, Kondo, Hidehiro, Hatayama, Yoshiomi, & Nakaji, Shigeyuki. Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume. United States. doi:10.1016/J.IJROBP.2005.0.
Basaki, Kiyoshi, Abe, Yoshinao, Aoki, Masahiko, Kondo, Hidehiro, Hatayama, Yoshiomi, and Nakaji, Shigeyuki. Wed . "Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume". United States. doi:10.1016/J.IJROBP.2005.0.
@article{osti_20793303,
title = {Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume},
author = {Basaki, Kiyoshi and Abe, Yoshinao and Aoki, Masahiko and Kondo, Hidehiro and Hatayama, Yoshiomi and Nakaji, Shigeyuki},
abstractNote = {Purpose: To investigate the impact of tumor volume on overall survival in patients with Stage III non-small-cell lung cancer (NSCLC) treated with definitive radiation therapy (RT). Methods and Materials: Between May 1997 and February 2003, 71 patients with Stage III NSCLC were treated with radiation therapy of 60 Gy or more. The total target dose was between 60 and 77 Gy (average, 66.3 Gy). Chemotherapy was used in 45 cases. The primary tumor and nodal volume were identified in pretreatment computed tomography scans. Univariate and multivariate analyses were used to evaluate the impact of tumor volume on survival after RT. Results: The overall 2-year survival rate was 23%, with a median survival time of 14 months. The median survival times were 10 months and 19 months with large primary tumor volume more than median volume and smaller primary tumor volume, respectively. At a univariate analysis, the total tumor volume (TTV) (p < 0.0003) and the primary tumor volume (p < 0.00008) were significant and the nodal volume was not. At multivariate analyses, both the TTV and the primary tumor volume were significant prognostic factors. Conclusion: The primary tumor volume as well as TTV is a significant prognostic factor on survival in patients with Stage III NSCLC treated with RT and should be recorded in clinical results when the survivals are compared among clinical studies.},
doi = {10.1016/J.IJROBP.2005.0},
journal = {International Journal of Radiation Oncology, Biology and Physics},
number = 2,
volume = 64,
place = {United States},
year = {Wed Feb 01 00:00:00 EST 2006},
month = {Wed Feb 01 00:00:00 EST 2006}
}